✉news ScienceScience first seen 1 d ago, last 20 h ago, peak #7
Roche highlights breakthroughs in targeting KRAS mutations
Original: From science fiction to scientific reality in the quest to target KRAS
Roche is highlighting progress in targeting KRAS, a cancer-driving protein long considered undruggable. The company describes the shift from science fiction to scientific reality, as new therapies finally show potential against mutations found in many cancers. The piece reflects growing optimism in oncology about precision medicines aimed at previously untouchable molecular targets.
Why now: Ongoing excitement about newly developed drugs against KRAS, once thought impossible to target, is drawing attention to cancer research advances.
Rank over time, top of the chart is #1. 2 snapshots from 22 h ago to 20 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/3204182